Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES, safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES. PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
Phentermine and topiramate extended-release capsules are indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Adult patients with obesity Adults with overweight in the presence of at least one weight-related comorbid condition Limitations of Use • The effect of phentermine and topiramate extended-release capsules on cardiovascular morbidity and mortality has not been established. • The safety and effectiveness of phentermine and topiramate extended-release capsules in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
- generic_name
- phentermine and topiramate extended-release
- product_names
- Phentermine and Topiramate Extended-Release
- ndc
- 43598-624, 43598-625, 43598-626, 43598-627, 43598-624-30, 43598-625-30, 43598-626-30, 43598-627-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en